A bacterial agglutination assay, a toxin-neutralizing assay, and an enzyme-linked immunosorbent assay (ELISA) were used to compare antibodies against intestinal Aeromonas strains in serum samples from healthy carriers (n = 6), from patients with acute (n = 15) or chronic (n = 8) gastroenteritis, from patients with gastroenteritis caused by other enteropathogenic bacteria (n = 3), and from healthy blood donors (n = 50). Evaluation of the bacterial agglutination assay showed that it was not very useful. The sensitivity of the ELISA in patients with acute or chronic aeromonas-associated diarrhea was 30% (7 of 23 patients were positive), whereas the specificity was 74% (13 of 50 healthy donors were positive). Positive results in the ELISA correlated with immunoglobulin M and immunoglobulin G responses to lipopolysaccharides of homologous Aeromonas strains, as determined by gel immunoradioassay and Western immunoblot analysis. The sera showed cross-reactions with heterologous Aeromonas strains and with Escherichia coli strains. The toxinneutralizing assay was positive in 5 of 11 patients who had developed acute severe diarrhea associated with cytotoxin-producing Aeromonas strains (46% sensitivity), whereas only 3 of 50 healthy donors had low serum titers of cytotoxin-neutralizing antibodies (94% specificity). All five patients were over 60 years of age. Cytotoxin-neutralizing activity was not observed in the sera of other groups of patients with aeromonads in their feces. We concluded that the three different serologic assays were not consonant with one another and that only the toxin-neutralizing assay distinguished patients with acute diarrhea from other groups of patients.
The clinical significance of various Aeromonas species in the human intestinal tract is a controversial topic. The results of studies on the association between virulence properties of the Aeromonas strains and gastrointestinal infections are contradictory (1, 7, 8, 13, 14, 19, 20) . We recently showed that 66 (39%) of 169 Aeromonas strains were isolated from patients who had a mixed infection with a known enteric pathogen, who had an underlying illness, who had previously been treated with penicillin derivates or antacids, or who had had immunotherapy (12) . The agerelated occurrence of various Aeromonas species in human feces and the occurrence of Aeromonas bacteremia in patients with immunosuppression also imply that host factors and previous medication are of substantial importance in the spectrum of aeromonas-associated disease (2, 10, (12) (13) (14) .
By analogy with Vibrio cholerae infection, the human serologic response to the presence of aeromonads in the intestinal tract may be directed against exotoxins produced by Aeromonas spp. Some Aeromonas species produce a toxin that immunologically cross-reacts with cholera toxin (6, 25) . On the other hand, intestinal infection by V. cholerae correlates better with a rise in serum antisomatic (0-antigen) antibodies than with an antitoxin response (30) . This suggests that studies on the immune response to aeromonads must also give consideration to antibodies against the O antigens of aeromonads.
The purpose of this investigation was to study the human serum antibody response to fecal Aeromonas isolates from different hybridization groups (HGs) . Serum antibodies to Aeromonas strains and to toxins of Aeromonas strains in * Corresponding author.
healthy carriers, in patients with aeromonas-associated diarrhea, and in healthy blood donors were studied.
MATERIALS AND METHODS Sera and bacteria. Serum specimens were collected from patients with Aeromonas veronii-associated diarrhea (n = 11), A. hydrophila-associated diarrhea (n = 5), A. mediaassociated diarrhea (n = 1), or A. caviae-associated diarrhea (n = 6) and from patients with mixed infections from which an Aeromonas strain and a known enteropathogenic species were isolated (n = 3) ( Table 1) . Also included were serum specimens from healthy individuals with A. hydrophila (n = 1), A. veronii (n = 1), or A. caviae (n = 4) in their feces. The clinical significance and phenotypic characteristics of the Aeromonas strains used in this study have been described previously (12) (13) (14) . Aeromonas strains were identified to species level by DNA relatedness studies with the reference strains from the 11 known Aeromonas hybridization reference groups, as previously described (15, 23 Pi, 1986) . Serum samples from 50 healthy blood donors (who had no history of recent diarrhea) were used to set up a cutoff level for the enzymelinked immunosorbent assay (ELISA) and the toxin-neutralizing-antibody assay. In addition, the sera were pooled and used as a reference serum in the ELISA. Convalescentphase serum from a 54-year-old male with septicemia caused by A. veronii was used as a standard positive control serum. Serum from a 1-month-old healthy baby without aeromonads in his feces was included in each assay as a negative control serum.
Isolation of cell envelopes. Cell envelopes were isolated SERUM ANTIBODY RESPONSE TO AEROMONADS 585 (31) , except that the cells were extracted twice. After removal of phenol by ether extraction, LPS were purified by ultracentrifugation (done twice) at 100,000 x g for 4 h. LPS were dialyzed for 24 h against deionized water, lyophilized, and stored at -20°C. Capsular polysaccharides were isolated by Cetavlon precipitation, dissociation in 1.0 M CaCi2, phenol extraction, and ultracentrifugation as described by 0rskov et al. (21) .
Protein A affinity chromatography of serum. Protein A affinity chromatography was done by conventional methods described in detail previously (27) Toxin-neutralizing assays. Aeromonas strains were grown in 5 ml of brain heart infusion broth for 14 h at 34°C in a shaking water bath. The filtered supernatant was diluted twofold in 1 ml of Eagle minimal essential medium (Flow Laboratories, Irvine, United Kingdom) containing gentamicin (20 ,ug/ml), penicillin (100 U/ml), and amphotericin B (1 ug/ml). Subsequently, the supernatant was transferred to a 3-day-old monolayer of Vero cells. After incubation for 16 h at 34°C, the cells were examined microscopically, and the cytotoxic titer was defined as the highest dilution that gave distinct degeneration or vacuolization for 50% of the cells. Indirect noncompetitive solid-phase ELISA. For ELISA (27) , microdilution plates (Greiner) were coated with cell envelopes (10 ,ug of protein per ml) in 0.1 ml of PBS per well during an overnight incubation at room temperature. After VOL. 28, 1990 on October six washes with PBS containing 0.5% (vol/vol) Tween 20 (PBS-T), the wells were postcoated with 3% bovine serum albumin (radioimmunoassay grade; Sigma Chemical Co., St. Louis, Mo.) in PBS for 2 h at 37°C and washed three times with PBS-T. Serum dilutions were prepared serially from 1:200 to 1:25,600 in PBS, and 0.1 ml of each serum dilution was added to duplicate wells of vertical rows in the microdilution plates. Serum samples from each patient, a pooled serum from 50 healthy blood donors, a positive control serum, and a negative control serum were tested against cell envelopes of the bacterial strains of the same patient. After incubation for 2 h at 37°C, the microdilution plates were washed six times with PBS-T, and then conjugate (goat anti-human IgG, gamma chain specific, labeled with horseradish peroxidase; Tago Inc., Burlingame, Calif.) was added at the optimal dilution (as indicated by the manufacturer) in PBS-T containing 0.5% bovine serum albumin. After incubation for 3 h at 37°C and six washes with PBS-T, 0.1 ml of substrate solution was added to each well. The substrate solution was prepared just before use and consisted of 0.02 M ortho-phenylenediamine (BDH Chemicals Ltd., Poole, United Kingdom) and 0.01% H202 in 50 mM phosphate-25 mM citric acid (pH 5.0). After incubation for 20 min in the dark at room temperature, the reaction was stopped by adding 30 Pl of 50% H2SO4 to each well. Absorbance was read at an optical density of 492 nm on a Titertek Multiskan (Flow Laboratories). Sera were tested in duplicate, and the antigen-coated control well reading was subtracted from the mean optical density of the sera. The titer of each serum was extrapolated from the ELISA curve as the dilution which gave an optical density of 1.0. The absorbance value (optical density = 1) was always in the linear part of the sigmoid dose-response curves. To correct for differences in antigenic composition of the strains, titers were expressed relative to those of human pooled serum with the same antigen. Pooled serum of samples from 50 healthy donors served to calculate the titer of the negative group (N value), whereas the tested serum yielded the P value. Sera were considered positive if P/N ratios were greater than or equal to 1.8 (mean of the negative sera plus 2 standard deviations; see Results).
GIRA. Gel immunoradioassay (GIRA) was done by a modification of the method of Poolman and Zanen (22) . Cell envelopes of Aeromonas strains were suspended to a final concentration of 1 mg of protein per ml in a buffer containing 62.5 mM Tris hydrochloride (pH 6.8), 2% (wt/vol) sodium dodecyl sulfate (SDS), 10% (vol/vol) glycerol, 5% (vol/vol) 2-mercaptoethanol, and 0.001% (wt/vol) bromophenol blue and were boiled for 5 min. SDS-polyacrylamide gel electrophoresis was done by the method of Lugtenberg et al. (18) with concentrations of 12% acrylamide in the running gel and 5% acrylamide in the stacking gel. Boiled samples (20 ,ul) were applied to the gel. After electrophoresis for 3 h at 30 mA, SDS gels were frozen in liquid nitrogen and cut into 50-,um slices (5 by 5 cm) at -35°C with a 5030 microtome (Bright Instrument Co. Ltd., Huntingdon, United Kingdom).
Gel slices were stored at -20°C in ethanol-acetic acid (6:1) until use. Before use, the slices were washed with PBS and incubated with patient serum (1:10, diluted in PBS) for 30 min at room temperature and overnight at 4°C. After three washes with PBS at room temperature, the slices were incubated with 125I-protein A in PBS containing 0.5% bovine serum albumin and 0.01% Tween 80 for 2 h at room temperature, with 106 cpm per slice. After three washes with PBS (16 h each) at room temperature, the slices were autoradiographed on X-Omat-R film (Eastman Kodak Co., Rochester, N.Y.) at -70°C with one intensifying screen. Table 2 ). All five patients suffered from severe acute gastroenteritis, and three were hospitalized because of diarrhea. In one of these five patients (A-87), seroconversion against the cytotoxin and a 10-fold rise in titer against the hemolysin were observed. Five (83%) of six patients older than age 60 who had acute diarrhea responded to cytotoxins, whereas 0 (0%) of five patients younger than age 60 who had acute diarrhea responded (X2 = 4.65 [including Yates correction], P < 0.05). The positive serum samples of two patients (A-38 and A-12) were tested against cytotoxins and hemolysins in reciprocal reactions. The titers were identical to those of the toxins from the homologous strain.
GIRA. Paired serum specimens from 19 patients (8 patients from group 1, 7 from group 2, 2 from group 3, and 2 from group 4) were examined by GIRA for antibodies against cell envelopes of the homologous and heterologous Aeromonas strains, an Escherichia coli (03:K4) strain, a Pseudomonas aeruginosa strain, and a V. cholerae strain. Serum specimens from 10 patients (3 from group 1, 5 from group 2, and 2 from group 4) reacted with components from cell envelopes of the homologous Aeromonas strain. Serum specimens from 8 of these 10 patients also reacted with Aeromonas strains from other HGs (Fig. 1A) . Strains from identical HGs did not contain common antigens that were specific for the HG. Serum specimens from the 10 patients reacted with either a broad-band or a ladder pattern in the high-molecular-weight (40,000 to 80,000) regions of the gel, whereas serum specimens from 9 of the 10 patients had a broad smear present in the low-molecular-weight (10,000 to 25,000) fraction (Fig. 1B) . (Fig. 2) .
DISCUSSION
The genus Aeromonas contains at least 11 HGs that are difficult, or in some cases impossible, to phenotypically separate from each other (15, 23) . Strains belonging to certain HGs produce enterotoxins, cytotoxins, and hemolysins, but it is not clear if these toxins result from different molecules or the same molecule (16) . Some studies report a good correlation between enterotoxin production and hemolysin production, and other studies show that hemolysins of Aeromonas spp. are also cytotoxic to tissue-cultured cell lines (16, 29) . Recently, Kozaki et al. found that the hemolytic and enterotoxigenic activities of A. sobria are neutralized by a monoclonal antibody against the hemolysin, which suggests that one molecule acts as both enterotoxin and hemolysin (11) . The discrepancy that we noticed between the production of hemolysins and that of cytotoxins in 6 of 19 Aeromonas strains may be explained by the insensitivity of rabbit erythrocytes to hemolysins of Aeromonas strains (3) . Another possibility may be the requirement of trypsin activation of the cell-free hemolysin for maximal expression (11) . This led us to use separate neutralizing assays for hemolysins and cytotoxins, but it remains possible that some neutralizing antibodies neutralize a hemolysin which also has cytotoxic activity. The results from our previous study (12) showed that noncytotoxigenic Aeromonas strains belonging to HG 4 and HG SA were isolated more frequently from human feces (67%) than were cytotoxigenic (to Vero cells) strains belonging to HGs 1, 2, 3, and 8 (33%). In addition, strains in HG 8 were cultured predominantly from patients with acute gastroenteritis, whereas strains in HG 1 were cultured from patients with chronic diarrhea. Thus, a different distribution of HGs existed in the four categories of patients that we have included in this study. The occurrence of HGs was age related, which also resulted in a different age distribution among the four categories.
The results from this study indicate that elderly patients with acute gastroenteritis may develop a serum antibody response to cytotoxins and hemolysins of Aeromonas strains. The specificity of the toxin-neutralizing assay was 94%, as determined by testing the serum specimens of 50 healthy blood donors. Toxin-neutralizing antibodies were present at high titers in 5 (46%) of 11 patients who had developed acute severe diarrhea associated with Aeromonas strains predominantly from HG 8. Interestingly, three of these five patients had bloody diarrhea. The six patients who did not respond to cytotoxins or hemolysins were not affected by immunosuppression from medication or underlying diseases. Only one of these six patients had bloody diarrhea. In addition, the feces of patient A-87 (who had developed a significant rise in toxin-neutralizing antibodies in serum) were examined for the presence of free fecal cytotoxins (12) . The stool extract of patient A-87 contained cytotoxins which could not be neutralized by Clostridium sordellii antitoxins and were suggestive of Aeromonas cytotoxins. However, neutralization with anti-Shiga toxin antibodies to exclude Shiga-like toxins was not performed.
All five patients who responded to hemolysins or cytotoxins were above the age of 60 and three were hospitalized because of severe diarrhea, suggesting that only severe damage to the intestinal tract will give rise to neutralizing
antitoxins. This hypothesis is strengthened by two published case reports on hospitalized patients with severe choleralike diarrhea who showed a rise in neutralizing antibody to Aeromonas toxins (5, 9). Cross-reacting antigens, such as cholera toxin and perhaps enterotoxins from E. coli or toxins from unidentified bacteria, however, could theoretically have produced serum antibodies in our patients (6, 26) . To establish the specificity of the neutralizing assay more carefully, further testing with cytotoxins and hemolysins from other bacterial species is warranted. The predominance of noncytotoxigenic Aeromonas isolates of HG 4 and HG 5A in human feces prompted us to investigate the human serum antibody response to surface components of Aeromonas strains by ELISA and bacterial agglutination. Agglutination was used by Caselitz et al., who described two patients with significant rises in serum-agglutinating antibodies against homologous Aeromonas strains: one patient had a chronic leg ulcer, and the other suffered from a liver abscess (4). We used homologous Aeromonas strains as antigens, because the genus Aeromonas is serologically heterogeneous in O antigens and H antigens and because of the great variation in protein profiles observed when the cell envelopes were examined by SDS-polyacrylamide gel electrophoresis (Kuijper and Peeters, Abstr. Int. Workshop Aeromonas, 1986 ). Evaluation of the bacterial agglutination assay showed that it was not very useful.
An ELISA was also done with homologous Aeromonas strains as antigen. Sera from 50 healthy blood donors were used to set up a cutoff value for the ELISA. The sensitivity (30%) and the specificity (74%) of the ELISA were disappointing, however. The results of the ELISA did not reveal differences between serum specimens from the four patient groups tested. A total of 3 (50%) of 6 individuals without gastrointestinal symptoms developed an antibody response to Aeromonas strains, which indicates that results from the ELISA do not discriminate between aeromonas-associated diarrhea and asymptomatic colonization. GIRA results suggested that cross-reactions in ELISA may be due to preexisting antibodies not only to Aeromonas strains but also to E. coli. Fecal samples containing known enteropathogenic bacteria in addition to aeromonads also gave rise to serum antibody responses against Aeromonas strains. A poor correlation was found between ELISA results and toxin-neutralizing assays, since only two of five patients who developed neutralizing antibodies were positive in the ELISA. When the patient group with mixed infections was excluded, positive ELISA results were observed in patients with Aeromonas strains in HG 8 (50% positive) and HG 4 (17% positive) in their feces. Patients with positive fecal cultures of Aeromonas strains in HG 1 (n = 6) were negative in the ELISA and in bacterial agglutination and toxin-neutralizing assays. This is an interesting observation, since Aeromonas strains in HG 1 were cultured predominantly from patients with chronic diarrhea.
The results of bacterial agglutination assays and ELISA supported the concept of immunological variation and relatedness among Aeromonas strains. When examined qualitatively by GIRA (IgG) and Western immunoblotting (IgM), antibodies were most frequently directed against the O antigens of homologous Aeromonas strains, but also against some heterologous strains. The IgG antibodies also showed some cross-reaction with polysaccharides from E. coli, although this response was weaker than that with Aeromonas strains. No common specific antigens were found among strains from identical HGs. Sakazaki and Shimada reported at least 44 0 antigens in the mesophilic Aeromonas species, some of which are immunologically related to O antigens of Vibrio species and Plesiomonas shigelloides (24) . Studies of the association of gastroenteritis and the occurrence of LPS with O polysaccharides of Aeromonas spp. have not been done and may be of particular interest for non-toxin-producing Aeromonas strains. In summary, of three different serologic assays developed to measure serum antibody response against intestinal Aeromonas strains, only the toxin-neutralizing assay distinguished patients with acute gastroenteritis from other groups of patients and from healthy blood donors. To study the diagnostic value of the toxin-neutralizing assay more carefully, further research is necessary to determine the antigen specificity and to increase the sensitivity of the assay.
